��������

Sven A. Wehrwein has served on our board of directors since November 2016. Mr. Wehrwein has been an independent financial consultant to emerging companies since 1999. During his more than 35 years in accounting and finance, Mr. Wehrwein has experience as an investment banker to emerging-growth companies, chief financial officer, and certified public accountant (inactive). Wehrwein currently serves on the boards of several companies, including Proto Labs, Inc. and SPS Commerce, Inc. In addition, he has served as a Director for a number of other medical device and high growth companies including tenures on the boards of Cogentix Medical, Inc., Compellent Technologies Inc., Synovis Life Technologies, Inc., and Vital Images. Mr. Wehrwein holds a B.S. in Business from Loyola University of Chicago and an M.S. in Management from the Sloan School, MIT. Mr. Wehrwein brings capabilities in financial understanding, strategic planning and auditing to the Board, given his experiences in investment banking and financial leadership positions. Mr. Wehrwein qualifies as an “audit committee financial expert” under SEC rules.